Flagship explainer

How United Therapeutics Corporation makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$3.2B · 100%Cost of revenue$384M · 12%Gross profit$2.8B · 88%Operating income$1.5B · 47%Income before tax$1.7B · 54%Income tax$379M · 12%Net income$1.3B · 42%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$3.2B100%
Cost of revenue$384M12%
$2.8B88%
$1.5B47%
Income before tax$1.7B54%
Income tax$379M12%
$1.3B42%
Source: · event Dec 31, 2025 · retrieved Sep 19, 2026 · annual-row source set
Embed this chart

View the full United Therapeutics Corporation analysis at Buy Like Buffett